Surya Bhatt, MD (PI)
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD >> See Study
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) >> See Study
Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/ REGN3500/ Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) >> See Study
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment With the Nuvaira™ Lung Denervation System in Patients With Chronic Obstructive Pulmonary Disease (COPD) >> See Study
Mark Dransfield, MD (PI)
A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease >> See Study
Treatment of Chronic Obstructive Pulmonary Disease (The Topic Trial) >> See Study
SPIROMICS Study of Early COPD Progression (SOURCE) >> See Study
Subpopulations and Intermediate Outcome Measures in COPD Study >> See Study
Zephyr Valve Registry (ZEVR) (ZEVR) >> See Study
The American Lung Association (ALA) Lung Health Cohort >> See Study
Tejaswini Kulkarni, MD (PI)
A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease >> See Study
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants With Pulmonary Fibrosis >> See Study
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis >> See Study
Tracy R. Luckhardt, MD (PI)
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Chronic Fibrosing Interstitial Lung Disease With Progressive Phenotype Prospective Outcomes (IPF-PRO/ILD-PRO) Registry >> See Study
Derek Russell, MD (PI)
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients >> See Study
Joseph Thachuthara-George, MD (PI)
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD >> See Study
James Wells, MD (PI)
A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-period Cross-over Study of the Effect of Ensifentrine on Sputum Markers of Inflammation in Patients With COPD >> See Study